Healthcare -
Biotechnology - NASDAQ - FR
$ 1.71
-6.56 %
$ 143 M
Market Cap
-2.55
P/E
IPHA - TOTAL EQUITY
Total Equity IPHA - Innate Pharma S.A.
51.9 M
LAST VALUE
-30.50%
2 YEAR CAGR
-20.87%
5 YEAR CAGR
2.57%
10 YEAR CAGR